Clinical trial NCT00586404 - References

Esophageal Neoplasms — The Study of Barrett's Esophagus: What Are the Factors of Progression

Citation(s)

•   45
  Sharma P, Reker D, Falk G, et al. Progression of Barrett's esophagus to high grade dysplasia and cancer - preliminary results of the Barrett's esophagus study trial. Gastroenterol 2001;120:A-16.
•   46
  Sharma P, Weston AP, Falk G, Johnston M, Reker D, Sampliner RE. Can two upper endoscopies negative for dysplasia eliminate the need for future surveillance in patients with Barrett's esophagus? Am J Gastroenterol 2001;96:(Supplement)109.
•   58
  Rosner. Fundamental of Biostatistics, New York, NY: Duxberry Press 1995.
•   59
  Hosmer, D.W. and S. Lemeshow. Applied Logistic Regression, New York, NY: John Wiley and Sons, 1989.
•   60
  Allison, P. D. Logistic Regression using the SAS System, Theory and Applications. Cary, NC. SAS Institute Inc, 1999.
•   61
  Harrell, F.E. Regression Modeling Strategies with Applications to Linear Models, Logistic Regression, and Survival Analysis. New York, NY Springer, 2001.
•   64
  Lipscomb SJ, Schoenfeld P, Johnston, Bethesda National Naval Med ctr, Bethesda. The incidence of high grade dysplasia and adenocarcinoma among patients with Barrett's esophagus: a cohort of 154 patients followed for a total of 471 patient-years. Gastroenterol 1999;116(4):A238.
•   Blot WJ, Devesa SS, Kneller RW, Fraumeni JF Jr
  Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA. 1991 Mar 13;265(10):1287-9.
•   Brown LM, Swanson CA, Gridley G, Swanson GM, Schoenberg JB, Greenberg RS, Silverman DT, Pottern LM, Hayes RB, Schwartz AG, et al
  Adenocarcinoma of the esophagus: role of obesity and diet. J Natl Cancer Inst. 1995 Jan 18;87(2):104-9.
•   Cameron AJ, Lomboy CT
  Barrett's esophagus: age, prevalence, and extent of columnar epithelium. Gastroenterology. 1992 Oct;103(4):1241-5.
•   Cameron AJ, Zinsmeister AR, Ballard DJ, Carney JA
  Prevalence of columnar-lined (Barrett's) esophagus. Comparison of population-based clinical and autopsy findings. Gastroenterology. 1990 Oct;99(4):918-22.
•   Cameron AJ
  Barrett's esophagus: prevalence and size of hiatal hernia. Am J Gastroenterol. 1999 Aug;94(8):2054-9.
•   Champion G, Richter JE, Vaezi MF, Singh S, Alexander R
  Duodenogastroesophageal reflux: relationship to pH and importance in Barrett's esophagus. Gastroenterology. 1994 Sep;107(3):747-54.
•   Chow WH, Blaser MJ, Blot WJ, Gammon MD, Vaughan TL, Risch HA, Perez-Perez GI, Schoenberg JB, Stanford JL, Rotterdam H, West AB, Fraumeni JF Jr
  An inverse relation between cagA+ strains of Helicobacter pylori infection and risk of esophageal and gastric cardia adenocarcinoma. Cancer Res. 1998 Feb 15;58(4):588-90.
•   Chow WH, Blot WJ, Vaughan TL, Risch HA, Gammon MD, Stanford JL, Dubrow R, Schoenberg JB, Mayne ST, Farrow DC, Ahsan H, West AB, Rotterdam H, Niwa S, Fraumeni JF Jr
  Body mass index and risk of adenocarcinomas of the esophagus and gastric cardia. J Natl Cancer Inst. 1998 Jan 21;90(2):150-5.
•   Csendes A, Braghetto I, Burdiles P, Puente G, Korn O, Díaz JC, Maluenda F
  Long-term results of classic antireflux surgery in 152 patients with Barrett's esophagus: clinical, radiologic, endoscopic, manometric, and acid reflux test analysis before and late after operation. Surgery. 1998 Jun;123(6):645-57.
•   Devesa SS, Blot WJ, Fraumeni JF Jr
  Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer. 1998 Nov 15;83(10):2049-53.
•   Drewitz DJ, Sampliner RE, Garewal HS
  The incidence of adenocarcinoma in Barrett's esophagus: a prospective study of 170 patients followed 4.8 years. Am J Gastroenterol. 1997 Feb;92(2):212-5.
•   Falk GW, Rice TW, Goldblum JR, Richter JE
  Jumbo biopsy forceps protocol still misses unsuspected cancer in Barrett's esophagus with high-grade dysplasia. Gastrointest Endosc. 1999 Feb;49(2):170-6.
•   Farrow DC, Vaughan TL, Hansten PD, Stanford JL, Risch HA, Gammon MD, Chow WH, Dubrow R, Ahsan H, Mayne ST, Schoenberg JB, West AB, Rotterdam H, Fraumeni JF Jr, Blot WJ
  Use of aspirin and other nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric cancer. Cancer Epidemiol Biomarkers Prev. 1998 Feb;7(2):97-102.
•   Freedman J, Ye W, Näslund E, Lagergren J
  Association between cholecystectomy and adenocarcinoma of the esophagus. Gastroenterology. 2001 Sep;121(3):548-53.
•   Funkhouser EM, Sharp GB
  Aspirin and reduced risk of esophageal carcinoma. Cancer. 1995 Oct 1;76(7):1116-9.
•   Gammon MD, Schoenberg JB, Ahsan H, Risch HA, Vaughan TL, Chow WH, Rotterdam H, West AB, Dubrow R, Stanford JL, Mayne ST, Farrow DC, Niwa S, Blot WJ, Fraumeni JF Jr
  Tobacco, alcohol, and socioeconomic status and adenocarcinomas of the esophagus and gastric cardia. J Natl Cancer Inst. 1997 Sep 3;89(17):1277-84.
•   Gray MR, Donnelly RJ, Kingsnorth AN
  The role of smoking and alcohol in metaplasia and cancer risk in Barrett's columnar lined oesophagus. Gut. 1993 Jun;34(6):727-31.
•   Hameeteman W, Tytgat GN, Houthoff HJ, van den Tweel JG
  Barrett's esophagus: development of dysplasia and adenocarcinoma. Gastroenterology. 1989 May;96(5 Pt 1):1249-56.
•   Kabat GC, Ng SK, Wynder EL
  Tobacco, alcohol intake, and diet in relation to adenocarcinoma of the esophagus and gastric cardia. Cancer Causes Control. 1993 Mar;4(2):123-32.
•   Katz D, Rothstein R, Schned A, Dunn J, Seaver K, Antonioli D
  The development of dysplasia and adenocarcinoma during endoscopic surveillance of Barrett's esophagus. Am J Gastroenterol. 1998 Apr;93(4):536-41.
•   Kuczmarski RJ, Flegal KM, Campbell SM, Johnson CL
  Increasing prevalence of overweight among US adults. The National Health and Nutrition Examination Surveys, 1960 to 1991. JAMA. 1994 Jul 20;272(3):205-11.
•   Lagergren J, Bergström R, Adami HO, Nyrén O
  Association between medications that relax the lower esophageal sphincter and risk for esophageal adenocarcinoma. Ann Intern Med. 2000 Aug 1;133(3):165-75.
•   Lagergren J, Bergström R, Lindgren A, Nyrén O
  Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med. 1999 Mar 18;340(11):825-31.
•   Lagergren J, Bergström R, Nyrén O
  Association between body mass and adenocarcinoma of the esophagus and gastric cardia. Ann Intern Med. 1999 Jun 1;130(11):883-90.
•   Levine DS, Haggitt RC, Blount PL, Rabinovitch PS, Rusch VW, Reid BJ
  An endoscopic biopsy protocol can differentiate high-grade dysplasia from early adenocarcinoma in Barrett's esophagus. Gastroenterology. 1993 Jul;105(1):40-50.
•   Lieberman D, Hamilton F
  NIH-ADHF Workshop on Endoscopy Priorities: workshop statement and recommendations. American Digestive Health Foundation. Gastrointest Endosc. 1999 Mar;49(3 Pt 2):S3-4.
•   McDonald ML, Trastek VF, Allen MS, Deschamps C, Pairolero PC, Pairolero PC
  Barretts's esophagus: does an antireflux procedure reduce the need for endoscopic surveillance? J Thorac Cardiovasc Surg. 1996 Jun;111(6):1135-8; discussion 1139-40.
•   Miros M, Kerlin P, Walker N
  Only patients with dysplasia progress to adenocarcinoma in Barrett's oesophagus. Gut. 1991 Dec;32(12):1441-6.
•   Montgomery E, Bronner MP, Goldblum JR, Greenson JK, Haber MM, Hart J, Lamps LW, Lauwers GY, Lazenby AJ, Lewin DN, Robert ME, Toledano AY, Shyr Y, Washington K
  Reproducibility of the diagnosis of dysplasia in Barrett esophagus: a reaffirmation. Hum Pathol. 2001 Apr;32(4):368-78.
•   O'Connor JB, Falk GW, Richter JE
  The incidence of adenocarcinoma and dysplasia in Barrett's esophagus: report on the Cleveland Clinic Barrett's Esophagus Registry. Am J Gastroenterol. 1999 Aug;94(8):2037-42.
•   Peters JH, Clark GW, Ireland AP, Chandrasoma P, Smyrk TC, DeMeester TR
  Outcome of adenocarcinoma arising in Barrett's esophagus in endoscopically surveyed and nonsurveyed patients. J Thorac Cardiovasc Surg. 1994 Nov;108(5):813-21; discussion 821-2.
•   Provenzale D, Schmitt C, Wong JB
  Barrett's esophagus: a new look at surveillance based on emerging estimates of cancer risk. Am J Gastroenterol. 1999 Aug;94(8):2043-53.
•   Reid BJ, Barrett MT, Galipeau PC, Sanchez CA, Neshat K, Cowan DS, Levine DS
  Barrett's esophagus: ordering the events that lead to cancer. Eur J Cancer Prev. 1996 Dec;5 Suppl 2:57-65.
•   Reid BJ, Blount PL, Feng Z, Levine DS
  Optimizing endoscopic biopsy detection of early cancers in Barrett's high-grade dysplasia. Am J Gastroenterol. 2000 Nov;95(11):3089-96.
•   Reid BJ, Haggitt RC, Rubin CE, Roth G, Surawicz CM, Van Belle G, Lewin K, Weinstein WM, Antonioli DA, Goldman H, et al
  Observer variation in the diagnosis of dysplasia in Barrett's esophagus. Hum Pathol. 1988 Feb;19(2):166-78.
•   Reid BJ, Levine DS, Longton G, Blount PL, Rabinovitch PS
  Predictors of progression to cancer in Barrett's esophagus: baseline histology and flow cytometry identify low- and high-risk patient subsets. Am J Gastroenterol. 2000 Jul;95(7):1669-76.
•   Robertson CS, Mayberry JF, Nicholson DA, James PD, Atkinson M
  Value of endoscopic surveillance in the detection of neoplastic change in Barrett's oesophagus. Br J Surg. 1988 Aug;75(8):760-3.
•   Romero Y, Cameron AJ, Locke GR 3rd, Schaid DJ, Slezak JM, Branch CD, Melton LJ 3rd
  Familial aggregation of gastroesophageal reflux in patients with Barrett's esophagus and esophageal adenocarcinoma. Gastroenterology. 1997 Nov;113(5):1449-56.
•   Rudolph RE, Vaughan TL, Storer BE, Haggitt RC, Rabinovitch PS, Levine DS, Reid BJ
  Effect of segment length on risk for neoplastic progression in patients with Barrett esophagus. Ann Intern Med. 2000 Apr 18;132(8):612-20.
•   Sampliner RE
  Practice guidelines on the diagnosis, surveillance, and therapy of Barrett's esophagus. The Practice Parameters Committee of the American College of Gastroenterology. Am J Gastroenterol. 1998 Jul;93(7):1028-32.
•   Schnell TG, Sontag SJ, Chejfec G, Aranha G, Metz A, O'Connell S, Seidel UJ, Sonnenberg A
  Long-term nonsurgical management of Barrett's esophagus with high-grade dysplasia. Gastroenterology. 2001 Jun;120(7):1607-19.
•   Shaheen NJ, Crosby MA, Bozymski EM, Sandler RS
  Is there publication bias in the reporting of cancer risk in Barrett's esophagus? Gastroenterology. 2000 Aug;119(2):333-8. Review.
•   Sharma P, Sampliner RE, Camargo E
  Normalization of esophageal pH with high-dose proton pump inhibitor therapy does not result in regression of Barrett's esophagus. Am J Gastroenterol. 1997 Apr;92(4):582-5.
•   Sharma P, Weston AP, Morales T, Topalovski M, Mayo MS, Sampliner RE
  Relative risk of dysplasia for patients with intestinal metaplasia in the distal oesophagus and in the gastric cardia. Gut. 2000 Jan;46(1):9-13.
•   Sharma P
  Controversies in Barrett's esophagus: management of high grade dysplasia. Semin Gastrointest Dis. 2001 Jan;12(1):26-32. Review.
•   Streitz JM Jr, Andrews CW Jr, Ellis FH Jr
  Endoscopic surveillance of Barrett's esophagus. Does it help? J Thorac Cardiovasc Surg. 1993 Mar;105(3):383-7; discussion 387-8.
•   Terry P, Lagergren J, Hansen H, Wolk A, Nyrén O
  Fruit and vegetable consumption in the prevention of oesophageal and cardia cancers. Eur J Cancer Prev. 2001 Aug;10(4):365-9.
•   Terry P, Lagergren J, Ye W, Wolk A, Nyrén O
  Inverse association between intake of cereal fiber and risk of gastric cardia cancer. Gastroenterology. 2001 Feb;120(2):387-91.
•   Vaezi MF, Richter JE
  Role of acid and duodenogastroesophageal reflux in gastroesophageal reflux disease. Gastroenterology. 1996 Nov;111(5):1192-9.
•   van Sandick JW, van Lanschot JJ, Kuiken BW, Tytgat GN, Offerhaus GJ, Obertop H
  Impact of endoscopic biopsy surveillance of Barrett's oesophagus on pathological stage and clinical outcome of Barrett's carcinoma. Gut. 1998 Aug;43(2):216-22.
•   Vicari JJ, Peek RM, Falk GW, Goldblum JR, Easley KA, Schnell J, Perez-Perez GI, Halter SA, Rice TW, Blaser MJ, Richter JE
  The seroprevalence of cagA-positive Helicobacter pylori strains in the spectrum of gastroesophageal reflux disease. Gastroenterology. 1998 Jul;115(1):50-7.
•   Weinstein WM, Ippoliti AF
  The diagnosis of Barrett's esophagus: goblets, goblets, goblets. Gastrointest Endosc. 1996 Jul;44(1):91-5.
•   Weston AP, Badr AS, Hassanein RS
  Prospective multivariate analysis of clinical, endoscopic, and histological factors predictive of the development of Barrett's multifocal high-grade dysplasia or adenocarcinoma. Am J Gastroenterol. 1999 Dec;94(12):3413-9.
•   Weston AP, Krmpotich PT, Cherian R, Dixon A, Topalosvki M
  Prospective long-term endoscopic and histological follow-up of short segment Barrett's esophagus: comparison with traditional long segment Barrett's esophagus. Am J Gastroenterol. 1997 Mar;92(3):407-13.
•   Weston AP, Sharma P, Topalovski M, Richards R, Cherian R, Dixon A
  Long-term follow-up of Barrett's high-grade dysplasia. Am J Gastroenterol. 2000 Aug;95(8):1888-93.
•   Williamson WA, Ellis FH Jr, Gibb SP, Shahian DM, Aretz HT
  Effect of antireflux operation on Barrett's mucosa. Ann Thorac Surg. 1990 Apr;49(4):537-41; discussion 541-2.

Barrett's Esophagus Study (BEST) Trial - a Multi-Center and Endoscopic Outcomes Project

Details for clinical trial NCT00586404